CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionProfit margin is 33.7%, higher than 95% of its Medical Devices peers (median 4.8%)
- FinancialsHigh earnings quality
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.82%Below 5Y avg (0.96%)
Annual Rate
CNY 0.26Paid annual
Payout Ratio
40.2%Sustainable
Last Ex-Dividend
Jun 4, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.35BCNY498.79M · vs all stocks (USD)
Trailing P/E
38.54xvs Medical Devices peers
Revenue (TTM)
254.90MCNY37.91M · vs all stocks (USD)
Profit Margin
33.65%vs Medical Devices peers
Beta
0.5080xvs all stocks
52-Week Change
13.14%vs all stocks
Market Capitalization
3.35BCNY498.79M · vs all stocks (USD)
Enterprise Value
1.90BCNY282.13M · vs all stocks (USD)
Trailing P/E
38.54xvs Medical Devices peers
Forward P/E
19.86xvs Medical Devices peers
Price to Sales (TTM)
13.16xvs Medical Devices peers
Price to Book (MRQ)
1.92xvs Medical Devices peers
Enterprise to Revenue
7.44xvs Medical Devices peers
Enterprise to EBITDA
20.27xvs Medical Devices peers
Gross Margin
64.42%vs Medical Devices peers
Profit Margin
33.65%vs Medical Devices peers
Operating Margin
32.92%vs Medical Devices peers
Return on Assets (TTM)
2.87%vs Medical Devices peers
Return on Equity (TTM)
5.09%vs Medical Devices peers
Revenue (TTM)
254.90MCNY37.91M · vs all stocks (USD)
Revenue per Share (TTM)
2.44CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-12.20%vs Medical Devices peers
Gross Profit (TTM)
158.39MCNY23.55M · vs all stocks (USD)
EBITDA (TTM)
94.82MCNY14.10M · vs all stocks (USD)
Net Income (TTM)
85.78MCNY12.76M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-16.50%vs Medical Devices peers
Operating Cash Flow (TTM)
95.02MCNY14.13M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
9.15MCNY1.36M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2600CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.82%vs all stocks
5-Year Average Dividend Yield
0.96%vs all stocks
Payout Ratio
40.24%vs Medical Devices peers
Minority Interest (Equity)
-156.60KCNYFY2025 · Dec 31, 2025Revenue
263.24MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
100.81MCNYFY2025 · Dec 31, 2025Gross Profit
162.44MCNYFY2025 · Dec 31, 2025Operating Income
84.25MCNY12.53M · vs all stocks (USD)
Pre-tax Income
103.14MCNYFY2025 · Dec 31, 2025Income Tax Expense
13.62MCNYFY2025 · Dec 31, 2025Net Income
89.52MCNYFY2025 · Dec 31, 2025EBIT
103.14MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
116.36MCNYFY2025 · Dec 31, 2025Research & Development
19.34MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
20.47MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
15.06MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.51KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.8500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.8500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
105.41MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
105.41MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
89.52MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
77.36KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
75.19MCNYFY2025 · Dec 31, 2025Free Cash Flow
41.64MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
759.69MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
89.52MCNYFY2025 · Dec 31, 2025Other Non-cash Items
2.01MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-14.24MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-2.10MCNYFY2025 · Dec 31, 2025Capital Expenditures
-33.55MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.70BCNYFY2025 · Dec 31, 2025Sale of Investments
1.41BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-326.91MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-34.31MCNYFY2025 · Dec 31, 2025Other Financing Charges
-11.82MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-46.13MCNYFY2025 · Dec 31, 2025Shares Outstanding
106.14MSharesUpdated Aug 21, 2026Float Shares
46.08MSharesUpdated Aug 21, 2026% Held by Insiders
55.59%vs all stocks
% Held by Institutions
0.66%vs all stocks
Total Cash (MRQ)
1.30BCNY193.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
12.51CNYUpdated Aug 21, 2026Total Debt (MRQ)
24.39KCNY3.63K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0000xvs Medical Devices peers
Current Ratio (MRQ)
20.80xvs Medical Devices peers
Book Value per Share (MRQ)
16.44CNYUpdated Aug 21, 2026Total Assets
1.77BCNY262.55M · vs all stocks (USD)
Total Current Assets
1.41BCNYFY2025 · Dec 31, 2025Total Liabilities
75.86MCNYFY2025 · Dec 31, 2025Total Non-current Assets
359.60MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
884.60KCNYFY2025 · Dec 31, 2025Total Current Liabilities
74.98MCNYFY2025 · Dec 31, 2025Cash
779.79MCNYFY2025 · Dec 31, 2025Cash Equivalents
184.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
779.79MCNYFY2025 · Dec 31, 2025Other Short-term Investments
500.39MCNYFY2025 · Dec 31, 2025Accounts Receivable
53.97MCNYFY2025 · Dec 31, 2025Inventory
42.47MCNYFY2025 · Dec 31, 2025Accounts Payable
17.87MCNYFY2025 · Dec 31, 2025Short-term Debt
48.03KCNYFY2025 · Dec 31, 2025Other Current Liabilities
856.95KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
884.60KCNYFY2025 · Dec 31, 2025Common Stock (Book)
106.14MCNYFY2025 · Dec 31, 2025Retained Earnings
570.37MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.69BCNY251.27M · vs all stocks (USD)
Treasury Stock
51.10MCNYFY2025 · Dec 31, 202552-Week Low
23.51CNYUpdated Aug 21, 202652-Week High
36.08CNYUpdated Aug 21, 202652-Week Change
13.14%vs all stocks
Beta
0.5080xvs all stocks
50-Day MA
27.86CNYUpdated Aug 21, 2026200-Day MA
28.57CNYUpdated Aug 21, 2026Avg 10-Day Volume
2.12MSharesUpdated Aug 21, 2026Avg 30-Day Volume
1.71MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.8200CNYUpdated Aug 21, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is 33.7%, higher than 95% of its Medical Devices peers (median 4.8%)Significant
Profit margin: 0.34Industry median: 0.05Industry P95: 0.32Peers compared: 102
Current ratio is 20.8×, higher than 95% of its Medical Devices peers (median 3.83×)Significant
Current ratio: 20.80Industry median: 3.83Industry P95: 12.54Peers compared: 102
Debt-to-equity is 0×, lower than 95% of its Medical Devices peers (median 0.11×)Notable
Debt-to-equity: 0.00Industry median: 0.11Industry P5: 0.00Peers compared: 102
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.61
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Hyundai Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai ZJ Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Huaren Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
OrthoPediatrics Corp.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Shen Lian Bio-Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Sd Biosensor Inc.
Tier 1ProductionApproval-Gated PipelineRule
Daewoong Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pku Healthcare Corporation Limited
Tier 1ProductionApproval-Gated PipelineRule
Valneva SE
Tier 1ProductionApproval-Gated PipelineRuleRisk
ProKidney Corp
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Montage Technology Co., Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Flytech Technology Co., Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Jiangxi JDL Environmental Protection Co. Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration